Counterfeit Avastin Marketed as Altuzan in US
The FDA has uncovered another batch of counterfeit cancer drug Avastin reports The Wall Street Journal. The fakes have been packaged in Altuzan packaging, which is the Turkish name for Avastin.
“Patients receiving cancer drugs or other drugs not approved by the FDA for the U.S. market may not be receiving needed therapy,” the FDA said. Non-counterfeit Altuzan, which is marketed in Turkey, isn’t approved for use in the U.S., reports USA Today.
